ArticleDigestive diseases and sciences2019
Epidemiological Trends in Gastrointestinal Cancers in China: An Ecological Study.
Article in Digestive diseases and sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Development of a novel diagnostic model integrating microRNAs and GALAD for HBV-related hepatocellular carcinoma.Biomarkers in medicine · 2025Article
- Investigating the mortality trend of gastrointestinal cancers in Babol, North Iran (2013-2021).BMC gastroenterology · 2024Article
- Evaluation of quality of life of gastrointestinal cancer patients presenting to a tertiary care hospital in Pakistan.Ecancermedicalscience · 2023Article
- Application of rational emotive behavior therapy in patients with colorectal cancer undergoing adjuvant chemotherapy.International journal of nursing sciences · 2022Article
- Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients.Frontiers in oncology · 2022Article
- Time trends of major cancers incidence and mortality in Guangzhou, China 2004-2015: A Joinpoint and Age-Period-Cohort Analysis.Cancer medicine · 2021Article
- Glycosylated Hemoglobin as an Age-Specific Predictor and Risk Marker of Colorectal Adenomas in Non-Diabetic Adults.Frontiers in endocrinology · 2021Article
- The impact of sedation on quality metrics of colonoscopy: a single-center experience of 48,838 procedures.International journal of colorectal disease · 2020Article
- Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I.Acta pharmacologica Sinica · 2020Article
- Association between Hemoglobin Levels and Colorectal Polyps in Asymptomatic Chinese Adults.Gastroenterology research and practice · 2020Article
- Serum netrin-1 as a biomarker for colorectal cancer detection.Cancer biomarkers : section A of Disease markers · 2020Article
- Changing etiology of hepatocellular carcinoma.Journal of gastroenterology · 2020Article
- Population-Based Incidence, Mortality, And Survival For Gastrointestinal Cancers During 2006-2016 In Wuhan, Central China.Cancer management and research · 2019Article
- Cancer Burden and Attributable Risk Factors of Cancers in China: Epidemiological Insights and Comparisons With India.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn recent decades, the patterns and trends of gastrointestinal (GI) cancer epidemics in Chinese population have been changing.
aimsTo present the epidemiological trends and geographic distributions of four major GI cancers (esophageal cancer, stomach cancer, liver cancer and colorectal cancer) in China from 2010 to 2014.
methodsIt used standardized data extracted from the National Central Cancer Registry database.
resultsThe age-standardized incidence rates (ASIR) of esophageal cancer decreased from 16.7 to 12.2 per 100,000 and the age-standardized mortality rates (ASMR) decreased from 12.0 to 8.8 per 100,000. The ASIR and the ASMR of stomach cancer dropped from 23.7 to 19.5 per 100,000 and from 16.6 to 13.3 per 100,000. The ASIR of liver cancer fell from 21.4 to 17.8 per 100,000 and its ASMR fell from 18.4 per 100,000 to 15.3 per 100,000. The ASIR of colorectal cancer increased from 16.1 to 17.5 per 100,000, whereas the ASMR fluctuated between 7.6 and 7.9 per 100,000. Moreover, the incidence and mortality of each cancer differed between males and females, urban and rural residence, as well as various regions.
conclusionFrom 2010 to 2014, esophageal cancer, stomach cancer and liver cancer showed downward trend, while the ASIR of colorectal cancer slightly rose and its ASMR presented stable.
Indexed as
Identifiers
30350242What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.